학술논문

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin
Document Type
Article
Source
In: Annals of Oncology. (Annals of Oncology, November 2022, 33(11):1179-1185)
Subject
Language
English
ISSN
15698041
09237534